Fluoxymesterone (Halotestin)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 01:06, 28 April 2022 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Androgen and anabolic steroid

Diseases for which it was used

Breast cancer

History of changes in FDA indication

10/15/1956: Initial FDA approval

Also known as

Brand names: Halotestin, Ultandren

Retrieved from "https://hemonc.org/w/index.php?title=Fluoxymesterone_(Halotestin)&oldid=55854"